Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective

Peer Review reports

Original Submission
4 Jul 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
9 Oct 2013	Author responded	Author comments - Virginia Pascual-Ramos
Resubmission - Version 3
9 Oct 2013	Submitted	Manuscript version 3
Publishing
26 Nov 2013	Editorially accepted
1 Dec 2013	Article published	10.1186/1471-2474-14-336

Back to article page